Sunday, June 30, 2013

Conjunctivitis increases reported in Japanese schoolkids due to eyeball licking (Video)

Japanese schoolteachers have been concerned of late because an increased number of middle school children have been showing up to class wearing eyepatches and sporting a raging case of conjunctivitis, or "pink eye", according to Daily Mail report June 13.

Image/Video Screen Shot
What is being called the new "second base", the new eyeball-licking trend called “worming", or technically “oculolinctus” is the latest expression between, let's say, two people who really like each other.
Definition: Oculolinctus refers to achieving sexual gratification from licking a person's eyeballs.
It's all the craze in Japan; however, this strange fetish doesn't come without risks.
It has led to a surge in cases of eye infections and can even cause blindness, doctors have warned,” the report said.
‘Nothing good can come of this,’ Dr David Granet, a San Diego ophthalmologist, told The Huffington Post. ‘There are ridges on the tongue that can cause a corneal abrasion. And if a person hasn't washed out their mouth, they might put acid from citrus products or spices into the eye.’
Dr Phillip Rizzuto, from the American Academy of Ophthalmology, added that eyeball licking can cause blindness as the bacteria found in the mouth can damage eye tissue.
Conjunctivitis is a common eye condition worldwide. It causes inflammation (swelling) of the conjunctiva -- the thin layer that lines the inside of the eyelid and covers the white part of the eye. Conjunctivitis is often called "pink eye" or "red eye" because it can cause the white of the eye to take on a pink or red color. The most common causes of conjunctivitis are viruses, bacteria, and allergens.
For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page
Looking for a job in health care? Check here to see what’s available

Texas: Guatemalan man, detained by Immigration, dies from rabies

A Guatemalan man being held in custody by U.S. Immigration and Customs Enforcement (ICE) since a month ago, has died from rabies, believed to be contracted prior to crossing the border,according to an ICE press release June 12.

According to immigration officials, the timeline of events related to 28-year-old Federico Mendez-Hernandez is as follows:
Mendez-Hernandez was taken into custody on May 9 by US Border Control on the Rio Grande and custody was transferred to on May 12. At the time he was captured, he showed no signs or symptoms of illness.
Approximately nine days after being apprehended, Mendez-Hernandez began to show some symptoms consistent with rabies and was ultimately taken to Christus Spohn Memorial Hospital in Corpus Christi.
Last Friday, laboratory analysis performed by the Centers for Disease Control and Prevention (CDC) confirmed Mendez-Hernandez had rabies.
It is unclear exactly how, when or where he contracted the lethal viral disease, information acquired via laboratory testing reveals he had a canine rabies virus variant common in Central America.

Federal and Texas health officials are interviewing people with contact with Mendez-Hernandez to determine rabies risk, such as contact with bodily fluid like saliva and tears to determine the need for post exposure rabies prophylaxis, despite there never being a confirmed person-to-person transmission of rabies.
According to the World Health Organization (WHO), Rabies is a zoonotic disease (a disease that is transmitted from animals to humans) that is caused by a virus. It is known to be present on all continents except Antarctica and infects domestic and wild animals.
Rabies is spread to people through close contact with infected saliva via bites or scratches. The main route of rabies transmission to humans is the bite of rabid dogs. Most of the deaths occur in the absence of post-exposure prophylaxis. Rabies is nearly always fatal when left untreated.
For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page
Looking for a job in health care? Check here to see what’s available

Purdue scientists have a jump on MERS coronavirus treatment going back to SARS

Image/Maureen Metcalfe; Azaibi Tamin
Researchers from the West Lafeyette, Indiana university have a "leg up" on developing a treatment for the new Middle East respiratory syndrome coronavirus, or MERS-CoV, thanks to work they did on a related virus in the past, according to a Purdue news release June 17.

The research team of Andrew Mesecar and Arun Ghosh, who previously created a compound that prevents replication of the virus that causes SARS, are testing compounds that could lead to potential treatments for the new MERS-CoV virus. Because of their previous research and expertise, the process will be reduced to months instead of years.
"MERS-CoV and SARS are similar, yet distinctly different coronaviruses," Mesecar said. "Our understanding of the prime targets for treatment of the SARS virus and the molecular inhibitors we have designed against it give us a good head start in finding a potential treatment for MERS-CoV."
"While MERS-CoV appears to be more virulent than SARS, molecular scaffolds and design concepts that we developed against SARS are very beneficial and timely," Ghosh said. "Using our expertise in structure-based design and drug development, our team has already synthesized a number of specific MERS-CoV inhibitors."
Globally, from September 2012 to date, WHO has been informed of a total of 77 laboratory-confirmed cases of infection with MERS-CoV, including 40 deaths.
Coronaviruses are a large family of viruses that includes viruses that may cause a range of illnesses in humans, from the common cold to SARS and animal diseases.
MERS-CoV is not the same coronavirus that caused SARS.
For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page
Looking for a job in health care? Check here to see what’s available